1. Mallick A, Gandhi PU, Gaggin HK, et al. The importance of worsening heart failure in ambulatory patients: definition, characteristics, and effects of amino-terminal pro-B-type natriuretic peptide guided therapy. JACC Heart Failure. 2016; 4(9):749-55.
2. Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002; 87(3):235-41.
3. Krotneva S, Kansal AR, Zheng Y, et al. Estimation of decrements of utility associated with hospitalizations in a population with heart failure from the systolic heart failure treatment with the if inhibitor ivabradine trial (SHIFT). Circulation. 2016; 134 (suppl_1):A16738-A.
4. Di Mauro M, Petroni R, Clemente D, et al. Clinical profile of patients with heart failure can predict rehospitalization and quality of life. J Cardiovasc Med. 2018; 19(3):98-104.
5. Heo S, Lennie TA, Okoli C, et al. Quality of life in patients with heart failure: ask the patients. Heart Lung. 2009; 38(2):100-8.
6. Okura Y, Ramadan MM, Ohno Y, et al. Impending epidemic future projection of heart failure in Japan to the year 2055. Circulation J. 2008; 72(3):489-91.
7. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017; 3(1):7.
8. Huffman MD, Prabhakaran D. Heart failure: epidemiology and prevention in India. The Natl Med J India. 2010; 23(5):283-8.
9. Konishi M, Ishida J, Springer J, et al. Heart failure epidemiology and novel treatments in Japan: facts and numbers. Wiley Online Library; 2016; 3: 145–151.
10. Hu SS, Kong LZ, Gao RL, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci. 2012;25(3):251-6.
11. Lam C. Heart failure in Southeast Asia: facts and numbers. ESC Heart Failure. 2015; 2 (2), 46–49.
12. Ahmadi A, Soori H, Mobasheri M, et al. Heart failure, the outcomes, predictive and related factors in Iran. J Mazandaran Univ Med Sci. 2014; 24(118):180-8.
13. Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: preventing disease and death worldwide. ESC Heart Failure. 2014; 1(1):4-25.
14. Shojaei F. Quality of Life in Patients with Heart Failure. Hayat of Journal. 2008;14(2):5-13.
15. Alla F, Briançon S, Guillemin F, et al. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail. 2002;4(3):337-43.
16. Audi G, Korologou A, Koutelekos I, et al. Factors affecting health related quality of life in hospitalized patients with heart failure. Cardiol Res Pract. 2017; 2017: 4690458.
17. Khariton Y, Nassif M, Thomas L, et al. Gender and Socioeconomic Disparities With Health Status in Outpatients With Heart Failure: Insights From the CHAMP-HF Registry. Circulation. 2017; 136(suppl_1): A19403.
18. Whitaker-Brown CD, Woods SJ, Cornelius JB, et al. Improving quality of life and decreasing readmissions in heart failure patients in a multidisciplinary transition-to-care clinic. Heart Lung. 2017;46(2):79-84.
19. Hallas CN, Wray J, Andreou P, et al. Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung. 2011;40(2):111-21.
20. Nordgren L, Sörensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs. 2003;2(3):213-7.
21. Zambroski CH, Moser DK, Bhat G, et al. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198-206.
22. Mangi MA, Rehman H, Rafique M, et al. Ambulatory heart failure monitoring: a systemic review. Cureus. 2017;9(4): e1174.
23. MacIver J, Wentlandt K, Ross HJ. Measuring quality of life in advanced heart failure. Curr Opin Support Palliat Care. 2017;11(1):12-6.
24. Westlake C, Dracup K, Creaser J, et al. Correlates of health-related quality of life in patients with heart failure. Heart Lung. 2002; 31(2):85-93.
25. Garin O, Herdman M, Vilagut G, et al. Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures. Heart Fail Rev. 2014; 19(3):359-67.
26. Jaski BE. The 4 stages of heart failure: Cardiotext Publishing; 2015.
27. Zhang Y, Bo Q, Lun S-s, et al. The 36-item short form health survey: reliability and validity in Chinese medical students. Int J Med Sci. 2012; 9(7):521-6.
28. Nieminen MS, Dickstein K, Fonseca C, et al. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol. 2015; 191:256-64.
29. Huber A, Oldridge N, Höfer S. International SF-36 reference values in patients with ischemic heart disease. Qual Life Res. 2016; 25(11):2787-98.
30. Abedi HA, Yasaman-Alipour M, Abdeyazdan GH. Quality of life in heart failure patients referred to the Kerman outpatient centers, 2010. J Shahrekord UunivMed Sci. 2011; 13(5): 55-63.
31. Barutcu CD, Mert H. The relationship between social support and quality of life in patients with heart failure. J Pak Med Assoc. 2013; 63(4):463-7.
32. Baghbeheshti M, Zolfaghari M, Rückerl R. Fine particulate matter (PM2. 5) and health effects: An unbridle problem in Iran. Galen Med J. 2017;6(2):81-94.
33. Bahador R, Nouhi E, Jahani Y. Quality of Life and its Related Factors in Patients with CHF, Referring to Jiroft Imam Khomeini Hospital. Iran J Nurs. 2017;30(105):23-33.
34. Köberich S, Lohrmann C, Mittag O, et al. Effects of a hospital-based education programme on self-care behaviour, care dependency and quality of life in patients with heart failure–a randomised controlled trial. J Clin Nurs. 2015; 24(11-12):1643-55.
35. Portney KE. Taking sustainable cities seriously: Economic development, the environment, and quality of life in American cities: MIT Press Direct; 2013.
36. Stampehl MR, Jennison SH, Call C, et al. Telehealth Heart Failure Program Associated With Improved Quality of Life. Circulation. 2017; 136(suppl_1): A20691.